APA

Clark R. E., Dodi I. A., Hill S. C., Lill J. R., Aubert G., Macintyre A. R., Rojas J., Bourdon A., Bonner P. L., Wang L., Christmas S. E., Travers P. J., Creaser C. S., Rees R. C. & Madrigal J. A. (20011221). Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. : Blood.

Chicago

Clark R E, Dodi I A, Hill S C, Lill J R, Aubert G, Macintyre A R, Rojas J, Bourdon A, Bonner P L, Wang L, Christmas S E, Travers P J, Creaser C S, Rees R C and Madrigal J A. 20011221. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. : Blood.

Harvard

Clark R. E., Dodi I. A., Hill S. C., Lill J. R., Aubert G., Macintyre A. R., Rojas J., Bourdon A., Bonner P. L., Wang L., Christmas S. E., Travers P. J., Creaser C. S., Rees R. C. and Madrigal J. A. (20011221). Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. : Blood.

MLA

Clark R E, Dodi I A, Hill S C, Lill J R, Aubert G, Macintyre A R, Rojas J, Bourdon A, Bonner P L, Wang L, Christmas S E, Travers P J, Creaser C S, Rees R C and Madrigal J A. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. : Blood. 20011221.